enocitabine has been researched along with Myelomonocytic Leukemia, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, S; Kikuchi, M; Misago, M; Mori, N; Nagata, K; Nakata, K; Oda, S; Otani, H; Sato, T; Tsukada, J | 1 |
| Dohy, H; Kyo, T | 1 |
2 other study(ies) available for enocitabine and Myelomonocytic Leukemia, Chronic
| Article | Year |
|---|---|
[Successful treatment with a small dose of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in a case of chronic myelomonocytic leukemia in blastic crisis].
Topics: Antineoplastic Agents; Blast Crisis; Cytarabine; Female; Humans; Leukemia, Myelomonocytic, Chronic; Middle Aged; Remission Induction | 1989 |
Results of aggressive chemotherapy for myelodysplastic syndromes.
Topics: Adult; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Male; Mercaptopurine; Middle Aged; Myelodysplastic Syndromes; Prednisolone; Remission Induction; Vincristine | 1988 |